Sofinnova Investments, Inc. Quant / Systematic

Location: Menlo Park, CA

CIK: 0001631134 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $2.631B (100.0% shares, 0.0% debt)

Holdings (74)

New Positions (30)

IWM iShares TR 5.7%
Value $149M Shares 600,000 Est. Cost Unrealized
XBI SPDR Series Trust 5.1%
Value $134M Shares 1,050,000 Est. Cost Unrealized
AZN AstraZeneca PLC 3.4%
Value $89.94M Shares 456,031 Est. Cost Unrealized
QQQ Invesco QQQ TR 3.3%
Value $86.58M Shares 150,000 Est. Cost Unrealized
IBB iShares TR 3.0%
Value $80.2M Shares 475,000 Est. Cost Unrealized
UTHR United Therapeutics Corp 1.8%
Value $47.62M Shares 80,300 Est. Cost Unrealized
BIIB Biogen Inc 1.6%
Value $42.08M Shares 229,521 Est. Cost Unrealized
CELC Celcuity Inc 1.3%
Value $34.24M Shares 300,000 Est. Cost Unrealized
AXSM Axsome Therapeutics Inc. 1.3%
Value $33.8M Shares 200,000 Est. Cost Unrealized
PFE Pfizer Inc 0.9%
Value $22.46M Shares 800,000 Est. Cost Unrealized
GMAB Genmab A/S 0.8%
Value $20.18M Shares 752,261 Est. Cost Unrealized
LQDA Liquidia Corporation 0.7%
Value $18.87M Shares 500,000 Est. Cost Unrealized
SYK Stryker Corporation 0.6%
Value $14.62M Shares 44,480 Est. Cost Unrealized
EXEL Exelixis Inc 0.4%
Value $10.79M Shares 251,500 Est. Cost Unrealized
ORIC Oric Pharmaceuticals Inc 0.3%
Value $8.61M Shares 679,578 Est. Cost Unrealized
TNGX Tango Therapeutics Inc 0.3%
Value $8.265M Shares 395,081 Est. Cost Unrealized
TYRA Tyra Biosciences Inc 0.3%
Value $7.814M Shares 204,015 Est. Cost Unrealized
REPL Replimune Group Inc 0.3%
Value $7.768M Shares 1,015,400 Est. Cost Unrealized
RARE Ultragenyx Pharmaceutical Inc 0.3%
Value $7.332M Shares 350,000 Est. Cost Unrealized
AXGN AxoGen Inc 0.3%
Value $6.979M Shares 210,665 Est. Cost Unrealized
DFTX Definium Therapeutics Inc 0.2%
Value $6.505M Shares 344,166 Est. Cost Unrealized
CYTK Cytokinetics Inc 0.2%
Value $6.05M Shares 91,791 Est. Cost Unrealized
MANE Veradermics Inc 0.2%
Value $4.63M Shares 73,315 Est. Cost Unrealized
HRMY Harmony Biosciences Hldgs Inc 0.2%
Value $4.277M Shares 152,695 Est. Cost Unrealized
PCVX Vaxcyte Inc 0.1%
Value $2.94M Shares 50,600 Est. Cost Unrealized
CMPX Compass Therapeutics Inc 0.1%
Value $2.645M Shares 500,000 Est. Cost Unrealized
TENX Tenax Therapeutics Inc 0.1%
Value $1.669M Shares 104,400 Est. Cost Unrealized
SEPN Septerna Inc 0.0%
Value $1.142M Shares 47,506 Est. Cost Unrealized
OKUR Onkure Therapeutics Inc 0.0%
Value $587K Shares 141,700 Est. Cost Unrealized
ZYME Zymeworks Inc 0.0%
Value $40,314 Shares 1,610 Est. Cost Unrealized

Increased Positions (24)

RARE Ultragenyx Pharmaceutical Inc 2.5%
Value $65.91M (+3340.0%) Shares 3,145,888 (+3676.6%) Est. Cost Unrealized
BMY Bristol-Myers Squibb Co 4.6%
Value $121M (+47.8%) Shares 1,988,721 (+31.4%) Est. Cost Unrealized
AXSM Axsome Therapeutics Inc. 1.4%
Value $35.96M (+1505.1%) Shares 212,747 (+1634.4%) Est. Cost Unrealized
INSM Insmed Inc 2.2%
Value $56.59M (+107.4%) Shares 346,075 (+120.7%) Est. Cost Unrealized
ALC Alcon AG 2.1%
Value $55M (+109.9%) Shares 729,972 (+119.5%) Est. Cost Unrealized
SUPN Supernus Pharmaceuticals 1.9%
Value $49.33M (+79.4%) Shares 954,309 (+72.5%) Est. Cost Unrealized
NKTR Nektar Therapeutics 1.4%
Value $36.66M (+97.7%) Shares 509,546 (+16.2%) Est. Cost Unrealized
UTHR United Therapeutics Corp 3.6%
Value $94.92M (+23.6%) Shares 160,070 (+1.5%) Est. Cost Unrealized
XENE Xenon Pharmaceuticals Inc 0.7%
Value $17.75M (+561.1%) Shares 305,216 (+409.5%) Est. Cost Unrealized
CELC Celcuity Inc 1.6%
Value $41.8M (+40.0%) Shares 366,175 (+22.3%) Est. Cost Unrealized
COGT Cogent Biosciences Inc 3.1%
Value $81.35M (+16.0%) Shares 2,113,551 (+7.1%) Est. Cost Unrealized
RYTM Rhythm Pharmaceuticals Inc 1.5%
Value $39.14M (+34.7%) Shares 450,096 (+65.8%) Est. Cost Unrealized
IDYA IDEAYA Biosciences Inc 1.4%
Value $37.71M (+23.2%) Shares 1,131,786 (+27.9%) Est. Cost Unrealized
BMRN BioMarin Pharmaceutical Inc 1.7%
Value $44.17M (+6.6%) Shares 781,982 (+12.2%) Est. Cost Unrealized
IMNM Immunome Inc 1.4%
Value $37.22M (+7.1%) Shares 1,701,904 (+5.2%) Est. Cost Unrealized
PHVS Pharvaris N V 0.9%
Value $23.12M (+11.8%) Shares 818,328 (+9.8%) Est. Cost Unrealized
WVE Wave Life Sciences Ltd 0.1%
Value $1.372M (-49.0%) Shares 189,253 (+19.6%) Est. Cost Unrealized
MIRM Mirum Pharmaceuticals Inc 0.1%
Value $2.549M (+39.7%) Shares 27,591 (+19.4%) Est. Cost Unrealized
DXCM Dexcom Inc 0.9%
Value $24.72M (-1.5%) Shares 393,576 (+4.1%) Est. Cost Unrealized
IMTX Immatics N.V 1.4%
Value $35.72M (-1.0%) Shares 3,630,454 (+5.7%) Est. Cost Unrealized
SVRA Savara Inc 0.1%
Value $1.992M (+8.4%) Shares 364,763 (+19.7%) Est. Cost Unrealized
ESTA Establishment Labs Hldgs Inc 0.1%
Value $1.927M (-6.8%) Shares 33,930 (+19.6%) Est. Cost Unrealized
SLNO Soleno Therapeutics Inc 0.0%
Value $492K (-14.4%) Shares 14,689 (+18.3%) Est. Cost Unrealized
ACAD Acadia Pharmaceuticals Inc 0.1%
Value $1.749M (-0.2%) Shares 78,551 (+19.8%) Est. Cost Unrealized

Exited Positions (16)

Decreased Positions (11)